237
POSTERS AND ELECTRONIC POSTERS
| PROGRAMME AND EXHIBITION GUIDE
ELECTRONIC POSTERS
> Stereotactic radiotherapy for recurrent pancreatic adnocarcinoma at
stump or abdominal lymph nodes
H.H. Wang (China), H.H. Wang, M.B. Meng, Z.Q. Wu, Y.C. Song,
H.Q. Zhuang, D. Qian, L.J. Zhao, Z.Y. Yuan
EP-1257
> Concurrent high-dose (60-70 Gy) radiation and chemotherapy for
esophageal cancer: long-term results
T. Kondo (Japan), Y. Shibamoto, A. Hayashi, A. Miyakawa, T. Murai,
T. Yanagi, C. Sugie, Y. Ogawa
EP-1258
> Clinical significance of lymphocyte count before chemoradiotherapy in
resected pancreatic cancer
J. Heo (Republic of Korea), O.K. Noh, H.W. Lee, M. Chun, Y.T. Oh, J. Kim
EP-1259
> Prognostic factors in hepatoma patients treated with radiotherapy for
lymph node metastasis
C.W. Wee (Republic of Korea), K. Kim, E.K. Chie, S.J. Yu, Y.J. Kim,
J.H. Yoon
EP-1260
> Impact of sarcopenia on adverse effects in trimodality therapy for
esophageal carcinoma
C. Panje (Switzerland), L. Höng, G. Henke, T. Ruhstaller, M. Guckenberger,
V. Baracos, L. Plasswilm
EP-1261
> Survival and symptom relief after salvage radio(chemo)therapy for
recurrent esophageal cancer
P.G. Kup, A. Gitt, H. Bühler, I.A. Adamietz, K. Fakhrian (Germany)
EP-1262
> Survival and symptom relief after palliative radiotherapy for esophageal
cancer
P.G. Kup, J. Welsch, H. Bühler, H. Hermani, I.A. Adamietz,
K. Fakhrian (Germany)
EP-1263
> Patterns of recurrence in stage pT3N0M0 thoracic ESCC patients after
two-field esophagectomy
Y.X. Wang (China), L.L. Wang, Z.S. Li, M. He, Q. Yang, J. Li, Z. Qi,
S.C. Zhu, X.Y. Qiao
EP-1264
> Salvage chemoradiation for locoregional recurrences of esophageal
cancer after curative treatment
P.M. Jeene (The Netherlands), E. Versteijne, E.D. Geijsen,
M.I. Van Berge Henegouwen, J.J.G.H.M. Bergmann, K. Muller,
H.W.M. Van Laarhoven, M.C.C.M. Hulshof
EP-1265